Back to calendar
ImmunityBio, Inc. (IBRX) Earnings
IBRX reports earnings on Wednesday, August 12, 2026
earnings report
August 12, 2026 · Before Market Open
Q2 2026
Est. EPS: $-0.09
Actual EPS: $-0.62
EPS surprise: -779.93%
Company overview
Market Cap$8.3B
PriceUSD 7.88
EPS (TTM)-0.85
52-week high12.43
52-week low1.95
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees691